Pharmabiz12h
Genprex starts patient dosing in phase 2 expansion portion of Acclaim-3 study of Reqorsa Gene Therapy in combo with Tecentriq to treat SCLC
Genprex starts patient dosing in phase 2 expansion portion of Acclaim-3 study of Reqorsa Gene Therapy in combo with Tecentriq to treat SCLC: Austin, Texas Friday, January 24, 2025 ...
Pharmabiz11h
Centre abdicates its constitutional obligation, criticises patients and experts on SMA issue
Centre abdicates its constitutional obligation, criticises patients and experts on SMA issue: Our Bureau, New Delhi Friday, January 24, 2025, 18:15 Hrs [IST] Patients and public h ...
Pharmabiz13h
Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab
Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab: New York Friday, January 24, 2025, 17:00 Hrs [IST] ...
Pharmabiz15h
Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection
Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...
Pharmabiz15h
IITH with NIMS unveils India’s digital pathology dataset, paves way for disease diagnosis and treatment
Our Bureau, Bengaluru Friday, January 24, 2025, 14:30 Hrs [IST] ...
Pharmabiz19h
Jaguar Health begins patient dosing in investigator-initiated POC trial of crofelemer for rare disease indication of MVID
San Francisco, California Friday, January 24, 2025, 11:00 Hrs [IST] ...
Pharmabiz15h
Kelun-Biotech’s novel ADC drug SKB445 receives NMPA approval to treat advanced solid tumours
Kelun-Biotech’s novel ADC drug SKB445 receives NMPA approval to treat advanced solid tumours: Chengdu Sichuan Province, PRC Friday, January 24, 2025, 15:00 Hrs [IST] Sichuan Kel ...
Pharmabiz16h
Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines
Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...
Pharmabiz14h
Lupin receives US FDA approval for sacubitril and valsartan tablets
Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...
Pharmabiz18h
Pharmapack award winners redefine packaging and drug delivery
Pharmapack award winners redefine packaging and drug delivery: Our Bureau, Mumbai Friday, January 24, 2025, 11:30 Hrs [IST] Pharmapack Europe has announced the winners of its newl ...
Pharmabiz18h
135 drug samples tested by the Centre and states in December declared as NSQs
The routine regulatory surveillance activity of the Central and State drug regulators has identified a total of 135 drug samples as Not of Standard Quality (NSQ) for the month of December, 2024. For ...
Pharmabiz21h
ImaginAb signs agreement to sell proprietary novel biologics technology platform to Telix Pharma
ImaginAb signs agreement to sell proprietary novel biologics technology platform to Telix Pharma: Inglewood, California Friday, January 24, 2025, 09:00 Hrs [IST] ImaginAb, Inc, a ...